COPD: New BODE Index May Be Better Predictor of Mortality

MedicalResearch.com Interview with: Dr. Juan P de Torres Pulmonary Department Clínica Universidad de Navarra Pamplona, Spain; MedicalResearch.com Interview with:
Dr. Juan P de Torres
Pulmonary Department
Clínica Universidad de Navarra
Pamplona, Spain;

MedicalResearch: What are the main findings of the study?

Dr. Torres: The BODE Index (BMI, Obstruction, Dyspnea, Exercise ) predicts mortality better than the GOLD ABCD (The Global Obstructive Lung Disease) grading and adding the COTE (Copd cO-morbidity TEst ) comorbidity Index to the BODE Index is complementary and provides an excellent predictive capacity for all-cause mortality in COPD patients.

MedicalResearch: What should clinicians and patients take away from your report?

Dr. Torres: Multidimensional evaluation in COPD patients including comorbidities allows us to more precisely predict short and long-term all-cause mortality.

MedicalResearch: What recommendations do you have for future research as a result of this study?

Dr. Torres: Future research in other COPD cohorts should confirm our findings and give support to the use of the BODE and COTE indexes in daily clinical practice.

Citation:

Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE

Juan P de Torres, Ciro Casanova, Jose M Marín, Victor Pinto-Plata, Miguel Divo, Javier J Zulueta, Juan Berto, Jorge Zagaceta, Pablo Sanchez-Salcedo, Carlos Cabrera, Santiago Carrizo, Claudia Cote, Bartolome R Celli

Thorax thoraxjnl-2014-205770Published Online First: 26 June 2014 doi:10.1136/thoraxjnl-2014-205770